Amelioration of docetaxel/cisplatin induced polyneuropathy by alpha-lipoic acid.
Gedlicka
C
C
Kornek
G V
GV
Schmid
K
K
Scheithauer
W
W
D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects* / Q000627:therapeutic use; D000975:Antioxidants / Q000494:pharmacology*; D002945:Cisplatin / Q000008:administration & dosage / Q000009:adverse effects; D000077143:Docetaxel; D005260:Female; D006801:Humans; D007262:Infusions, Intravenous; D008297:Male; D008875:Middle Aged; D017239:Paclitaxel / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives*; D011115:Polyneuropathies / Q000139:chemically induced* / Q000188:drug therapy*; D043823:Taxoids; D008063:Thioctic Acid / Q000494:pharmacology*
D000975:Antioxidants; D043823:Taxoids; D000077143:Docetaxel; D008063:Thioctic Acid; D017239:Paclitaxel; D002945:Cisplatin